Page last updated: 2024-08-23

etoposide and Glial Cell Tumors

etoposide has been researched along with Glial Cell Tumors in 158 studies

Research

Studies (158)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (4.43)	18.7374
1990's	51 (32.28)	18.2507
2000's	70 (44.30)	29.6817
2010's	26 (16.46)	24.3611
2020's	4 (2.53)	2.80

Authors

Authors	Studies
Barrows, LR; Ireland, CM; Kokoshka, JM	1
Furbacher, TR; Gunatilaka, AA	1
Andricopulo, AD; Beraldo, H; Da Silva, JG; Daghestani, H; Day, BW; Dos Santos, RG; Lessa, JA; Mendes, IC; Pesquero, JL; Rocha, WR; Salum, LB; Soares, MA; Vogt, A	1
Chen, J; Gao, X; Hou, X; Huang, H; Li, S; Shi, Q; Zhao, Y	1
Cao, Y; Chen, G; Jiang, X; Li, S; Zhang, L; Zhou, X	1
Dang, TT; Morales, JC	1
Bendau, E; Bruce, JN; Canoll, P; Englander, ZK; Feldstein, NA; Jan, CI; Konofagou, EE; McQuillan, NM; Pouliopoulos, AN; Spinazzi, EF; Tazhibi, M; Upadhyayula, P; Wang, TJC; Wei, HJ; Wu, CC; Yoh, N; Zacharoulis, S	1
Bison, B; Bojko, S; Gielen, GH; Hoffmann, M; Kortmann, RD; Kramm, CM; Pietsch, T; Seidel, C; von Bueren, AO; Warmuth-Metz, M	1
Babincová, M; Babinec, P; Durdík, Š; Sourivong, P; Vrbovská, H	1
Hu, D; Li, R; Luo, L; Ni, W; Wen, F; Xu, X; Zuo, P	1
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Riccardi, R; Ridola, V; Rizzo, D; Ruggiero, A	1
Leonard, A; Wolff, JE	1
Arola, M; Clausen, N; Harila-Saari, A; Holm, S; Kivivuori, SM; Lähteenmäki, P; Lannering, B; Lönnqvist, T; Porkholm, M; Riikonen, P; Saarinen-Pihkala, UM; Schomerus, E; Sehested, A; Thomassen, H; Thorarinsdottir, HK; Valanne, L; Wojcik, D	1
Blasiak, J; Lewandowska, U; Pastwa, E; Poplawski, T; Somiari, RI; Somiari, SB	1
Bailly, C; Bal-Mahieu, C; Boulet, E; Guilbaud, N; Kruczynski, A; Lansiaux, A; Lartigau, E; Leblond, P; Meignan, S; Pillon, A; Sarrazin, T	1
Huang, S; Nie, X; Wu, L; Xu, H; Yi, W; Zhu, X	1
Elhag, R; Mazzio, EA; Soliman, KF	1
Gratas, C; Nadaradjane, A; Oizel, K; Oliver, L; Pecqueur, C; Vallette, FM	1
Abriola, L; Fernandez, RJ; Glazer, PM; Hoyer, D; Hungerford, W; Liu, Y; Merkel, J; Peterson-Roth, E; Pike, LR; Qian, JM; Stachelek, GC	1
Al-Nedawi, K; Garnier, D; Guha, A; Lee, TH; Lee, WJ; Meehan, B; Montermini, L; Rak, J	1
Eisele, G; Roth, P; Tonder, M; Weller, M	1
Koo, HH; Lee, HJ; Lee, JW; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yi, ES; Yoo, KH	1
Mufazalov, FF; Sakaeva, DD; Shtefan, AIu	1
Ashley, DM; Dobrovic, A; Drummond, KJ; Friedman, HS; Gan, HK; Hawkins, CJ; Johns, TG; Kaye, AH; Lovric, MM; Maxwell, JA; Mikeska, T; Riffkin, CD	1
Cho, SG; Choi, HY; Choi, TW; Jeong, HS; Kim, BW; Kim, JH; Lee, ER	1
Chen, L; Cheng, J; Feng, P; Li, S; Long, D; Lu, Y; Zhou, D	1
Fujii, M; Ito, M; Natsume, A; Ohno, M; Wakabayashi, T	1
Mashima, T; Matsuura, M; Miyata, S; Okabe, S; Sato, S; Seimiya, H; Sugimoto, Y; Tsuruo, T	1
Hongo, H; Inui, K; Kishi, Y; Kodawara, T; Takahashi, J; Yano, I; Yano, Y	1
Bigner, DD; Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Marcello, JE; McLendon, RE; Norfleet, J; Reardon, DA; Sampson, JH; Sathornsumetee, S; Vredenburgh, JJ	1
Biassoni, V; Casanova, M; Catania, S; Clerici, CA; Gandola, L; Genitori, L; Giangaspero, F; Massimino, M; Meazza, C; Modena, P; Poggi, G; Potepan, P; Riva, D; Sardi, I; Simonetti, F; Solero, C; Spreafico, F	1
Kivivuori, SM; Lönnqvist, T; Riikonen, P; Saarinen-Pihkala, UM; Valanne, L	1
Ashley, DM; Bandopadhayay, P; Cohn, RJ; Downie, PA; Hassall, TE; Kirby, ML; Rosenfeld, JV; Sullivan, MJ; Wheeler, GC	1
Kim, JH; Lee, WH; Suk, K; Zheng, LT	1
Bartels, U; Bouffet, E; Dirks, P; Fried, I; Hawkins, C; Huang, A; Scheinemann, K; Tabori, U; Tsangaris, E	1
Boström, J; Glas, M; Herrlinger, U; Kim, Y; Mack, F; Rieger, J; Schäfer, N; Scheffler, B; Simon, M; Steinbach, JP; Stuplich, M; Thanendrarajan, S; Tichy, J	1
Desjardins, A; Sampson, JH	1
Guo, C; Li, H; Liu, C; Ma, C; Shi, Y; Song, X; Wang, Q; Wang, X; Zhang, L; Zhang, X; Zhu, F	1
Barbieri, NL; Cordero, EA; Filippi-Chiela, EC; Garcia-Santos, D; Lenz, G; Lopez, PL; Pelegrini, AL; Reder, GM; Silva, AO	1
Andry, MC; Callewaert, M; Dukic, S; Gafa, V; Molinari, M; Roullin, VG; Van Gulick, L; Vittier, M	1
Berger, MS; Boyett, JM; Bruggers, CS; Bruner, JM; Chan, KW; Dusenbery, KE; Ettinger, LJ; Fitz, CR; Holmes, E; Jennings, MT; Lafond, D; Mandelbaum, DE; Massey, V; McGuire, W; McNeely, L; Moulton, T; Pollack, IF; Shen, V; Sposto, R; Vezina, LG	1
Balestrini, MR; Casanova, M; Cefalo, G; Colosimo, C; Di Rocco, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Genitori, L; Luksch, R; Massimino, M; Mazza, E; Navarria, P; Riccardi, R; Riva, D; Ruggiero, A; Spreafico, F; Terenziani, M; Tesoro-Tess, JD; Valentini, L	1
Belenkov, AI; Chow, TY; Monia, BP; Paiement, JP; Panasci, LC	1
Gnekow, A; Kuehl, J; Mölenkamp, G; Rating, D; Warmuth-Metz, M; Westphal, S; Wolff, JE	1
Beauchesne, PD; Bertrand, S; Branche, R; Dore, JF; Linke, SP; Pedeux, RM; Revel, R	1
Benita-Weiss, M; Bushunow, P; Coyle, TE; Evans, B; Friedman, H; Korones, DN; Mechtler, L; Quinn, JA; Reardon, DA	1
Beauchesne, P; Boniol, M; Schmitt, T; Soler, C	1
Fukumoto, M; Hashimoto, N; Itoh, N; Kono, K; Murai, N; Myoumoto, A; Takahashi, JA; Ueba, T	1
Hara, N; Moritake, K; Osago, H; Shingu, T; Terashima, M; Tsuchiya, M; Uemura, T; Yamada, K; Yamasaki, T	1
Benyahia, B; Bernaudin, JF; Crinière, E; Declèves, X; Delattre, JY; Huguet, S; Mokhtari, K; Scherrmann, JM	1
Qi, ST; Qiu, BH	1
Cmelak, A; Jennings, MT; Johnson, MD; Moots, PL; Pais, R; Shyr, Y	1
Dawson, G; Dawson, SA; Moskal, JR	1
Dwarakanath, BS; Khaitan, D; Ravindranath, T	1
Bartolini, S; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Magrini, E; Paioli, A; Palmerini, E; Pession, A; Rimondini, S; Scopece, L	1
Matsumoto, Y; Nagao, S; Tamiya, T	1
Parent, AD; Tamaki, N; Yin, D; Zhang, JH	1
Benesch, M; Berthold, F; Wagner, S; Wolff, JE	1
Katayama, Y; Watanabe, T; Yoshino, A	1
Bouffet, E; Foreman, N; Korones, DN; Smith, A	1
Bernstein, M; Blaney, S; Chen, Z; Fisher, PG; Freeman, C; Friedman, H; Greenberg, ML; Hershon, L; Korones, DN; Kretschmar, C; Zhou, T	1
Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML	1
Bruns, PK; Daman, M; Doolittle, ND; Fortin, D; Hall, WA; Muldoon, L; Neuwelt, EA	1
Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK	1
Benoit, JP; Lamprecht, A	1
Cloughesy, TF; Lai, A; Mischel, P; Nghiemphu, P; Pope, WB	1
Berzioli, C; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Paioli, A; Paioli, G; Palmerini, E; Scopece, L; Spagnolli, F	1
Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS	1
Chen, X; Gu, J; Jiang, J; Kong, X; Shen, A; Shen, J; Sun, M; Wang, H; Wei, Y; Wu, T; Xie, J; Yang, Y; Zhang, S; Zong, H	1
Berger, MS; Katayama, M; Kawaguchi, T; Pieper, RO	1
Chastagner, P; Doz, F; Dufour, C; Frappaz, D; Gentet, JC; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Pichon, F; Plantaz, D; Puget, S; Raquin, MA	1
Benesch, M; Berthold, F; Gnekow, AK; Kortmann, RD; Pietsch, T; Rutkowski, S; Sträter, R; Wagner, S; Warmuth-Metz, M; Wolff, JE	1
Feun, LG; Heros, D; Herrera, C; Landy, H; Marini, A; Markoe, A; Robles, C; Savaraj, N	1
Chen, ZP; Mu, YG; Sai, K; Shi, HL; Yue, WY; Zhang, JP; Zhang, XH	1
Chen, Z; Fisher, PG; Freeman, C; Kepner, J; Korones, DN; Kretschmar, C; Zhou, T	1
Ido, K; Kubota, T; Matsuda, K; Nakagawa, T; Sakuma, T	1
Batchelor, TT; Black, PM; Bradshaw, J; Chen-Plotkin, AS; Doherty, L; Drappatz, J; Folkman, J; Gigas, DC; Kesari, S; Kieran, M; Kracher, J; Laforme, A; Levy, B; Muzikansky, A; O'Neill, A; Ramakrishna, N; Schiff, D; Weiss, SE; Wen, PY	1
Akiyama, H; Hasegawa, D; Kawamura, A; Kosaka, Y; Nagashima, T; Nakamizo, S; Takeda, H; Yoshida, M	1
Bianchi, G; Lee, C; Longo, VD; Madia, F; Raffaghello, L; Safdie, FM; Wei, M	1
Abschuetz, A; Geibig, R; Kees, T; Nickles, D; Régnier-Vigouroux, A; Spiess, E; Zimmer, H	1
Kessinger, A	1
Belanger, R; Dennery, JM; Gerin-Lajoie, J; Hopkins, HS; Hugenholtz, H; Montpetit, V; Nundy, D; Prior, J; Richard, MT; Stewart, DJ	1
Canetta, R; D'Incalci, M; Franchin, G; Galligioni, E; Grigoletto, E; Rossi, C; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A	1
Chamberlain, MC; Grafe, MR	1
Chamberlain, MC	3
Abe, T; Hasegawa, S; Hori, S; Kohno, K; Kuwano, M; Kuwano, T; Mori, T; Ono, M; Taniguchi, K; Yokomizo, A	1
Schmoor, C; Schumacher, M; Ulm, K	1
Hayakawa, T; Kanayama, T; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M	1
Fujita, T; Hayakawa, T; Kadota, T; Kanayama, T; Kubo, S; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M	1
Hotta, T; Kiya, K; Kurisu, K; Mikami, T; Ogasawara, H; Sugiyama, K; Uozumi, T	5
Fujita, T; Hagiwara, Y; Hiraoka, M; Kanayama, T; Kubo, S; Nakagawa, H; Nakanomyo, H; Tokiyoshi, K; Yamada, M	1
Forsyth, P; Fulton, D; Urtasun, R	1
Allen, JC; Siffert, J	1
Ameri, A; Delattre, JY; Monjour, A; Poisson, M; Ronchin, P; Sahmoud, T; Sanson, M	1
Bouffet, E; Brunat-Mentigny, M; Carrie, C; Frappaz, D; Jouvet, A; Mottolese, C; Philip, I	1
Ameri, A; Chauveinc, L; Chen, QM; Delattre, JY; Poisson, M	1
Cohen, IJ; Horev, G; Kornreich, L; Michowiz, S; Shuper, A; Weitz, R; Zaizov, R	1
Balmaceda, C; Fetell, MR; Hesdorffer, C	1
Furuta, T; Kuriyama, M; Matsumoto, K; Ohmoto, T; Ono, Y; Tamiya, T; Tsutsui, K	1
Gajjar, A; Heideman, R; Kun, LE; Langston, JW; Ochs, JS; Sanford, RA; Walter, AW	1
Beauchesne, P; Bertrand, S; Bonner, JA; Christianson, T; Dore, JF; Mornex, F; N'guyen, MJ	1
Alexander, MA; Alvord, WG; Arguello, F; Greene, JF; Jorden, JL; Kalavar, NT; Klabansky, RL; Sausville, EA; Smith, EM; Stinson, SF	1
Arita, N; Hayakawa, T; Hiraga, S; Ohnishi, T; Taki, T	1
Adams, G; Flynn, P; Grunnet, M; Hellman, R; Karp, D; Neuberg, DS; Robins, HI; Wagner, H	1
Drumea, K; Goldsher, D; Ravkin, A; Stein, ME; Tzuk-Shina, Z	1
Basu, S; Price, BD; Rosenzweig, KR; Youmell, M	1
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C	1
Isoe, S; Naganuma, H; Nagasaka, M; Nakano, S; Nukui, H; Sasaki, A; Satoh, E	1
Furuta, T; Maeda, Y; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Tamiya, T	2
Ames, MM; Bagniewski, PJ; Buckner, JC; Cascino, TL; Marks, RS; Rajkumar, SV; Reid, JM; Schomberg, PJ	1
Abe, T; Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M	1
Ciesielski, MJ; Fenstermaker, RA	1
Drumea, K; Goldsher, D; Kuten, A; Stein, ME; Tzuk-Shina, Z	1
Beauchesne, P; Brunon, J; Duthel, R; Fotso, MJ; Rusch, P; Schmitt, T; Soler, C	1
Chastagner, P; Chouffai, Z; Couanet, D; Doireau, V; Grignon, Y; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Marchal, JC; Zerah, M	1
Eskens, FA; Pronk, L; Sillevis Smitt, PA; van den Bent, MJ; Vecht, CJ; Verweij, J	1
Asai, A; Kuchino, Y; Nagane, M; Nomura, K; Oyama, H; Shibui, S	1
Frenay, M; Lebrun, C; Lonjon, M; Marcy, PY; Paquis, P	1
Horikoshi, T; Naganuma, H; Nukui, H; Ohashi, Y; Ueno, T	1
Kunishio, K; Matsumoto, Y; Nagao, S	1
Banno, Y; Nakashima, S; Nishimura, Y; Nozawa, Y; Sakai, N; Sawada, M; Shinoda, J; Takenaka, K; Yamakawa, H	1
Kokunai, T; Tamaki, N; Yin, D	1
Hao, YJ; Mizuno, M; Natsume, A; Taniguchi, K; Wakabayashi, T; Yoshida, J	1
Altaner, C; Bies, J; Hlavatý, J; Hlubinova, K; Tyukosova, S	1
Banáth, JP; Johnston, PJ; MacPhail, SH; Olive, PL; Oloumi, A	1
Abe, T; Hikawa, T; Hori, S; Mori, T	1
Aizu-Yokota, E; Hasegawa, M; Kasahara, T; Momoi, T; Sakurai, S; Sonoda, Y; Yamamoto, D	1
Arai, H; Beppu, T; Hakozaki, S; Kubo, N; Ogawa, A; Suzuki, M; Wada, T; Yoshida, Y	1
Bourg, V; Chichmanian, RM; Frenay, M; Lebrun, C; Thomas, P	1
Banno, Y; Kiyono, T; Nakagawa, M; Nakashima, S; Nishimura, Y; Nozawa, Y; Sakai, N; Sawada, M; Shinoda, J; Yamada, J; Yamakawa, H	1
Doolittle, ND; Jones, G; Lacy, C; Neuwelt, EA; Nickolson, HS; Osztie, E; Várallyay, P	1
Asai, A; Hamada, H; Kirino, T; Sakurai, S; Shinoura, N	1
Ashby, LS; Shapiro, WR	1
Nakanishi, Y; Nomura, K; Shibui, S; Tanaka, M	1
Lavicka, J; Mirossay, A; Mirossay, L; Mojzis, J; Sarisský, M; Sulla, I	1
Kherfellah, D; Montaudon, D; Pavillard, V; Richard, S; Robert, J	1
Darling, JL; Thomas, DG	1
Alcaraz, L; Benboubker, L; Bergemer-Fouquet, AM; Calais, G; Colombat, P; Destrieux, C; Jan, M; Linassier, C	1
Baujan, MA; Bourekas, EC; Chakeres, DW; Christoforidis, GA; Newton, HB; Slivka, MA; Stevens, CL	1
Boiardi, A; Botturi, M; Broggi, G; Milanesi, I; Silvani, A	2
Kaba, K; Matsumoto, T; Miyaji, K; Shindo, H; Tani, E	1
Arita, N; Fujita, T; Hayakawa, T; Kubo, S; Miyawaki, Y; Nakagawa, H; Tsuruzono, K	1
Boiardi, A; Botturi, M; Milanesi, I; Munari, L; Silvani, A; Solero, CL	1
Hotta, T; Kawamoto, K; Kiya, K; Kurisu, K; Mikami, T; Nakada, Y; Saito, Y; Uozumi, T; Yamada, K	1
Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD	1
Furuyama, J; Kaba, K; Kochi, N; Matsumoto, T; Sakamoto, H; Shindo, H; Tani, E; Yamamoto, Y	1
Hanada, R; Hayashi, Y; Inaba, T; Nishimoto, H; Tsukiyama, T; Yaginuma, A; Yamamoto, K	1
Peters, W; Souhami, R	1
Daly, MB; Harden, EA; Johnson, DB; Leff, RS; Mercier, RJ; Messerschmidt, GL; Thompson, JM	1
Feun, LG; Lee, YY; Savaraj, N; Wallace, S; Yung, WK	1

Reviews

5 review(s) available for etoposide and Glial Cell Tumors

Article	Year
Etoposide improves survival in high-grade glioma: a meta-analysis. Anticancer research, 2013, Volume: 33, Issue:8 Topics: Brain Neoplasms; Cohort Studies; Demography; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Survival Analysis; Topoisomerase Inhibitors	2013
[Genetic analysis and individualized therapy for diffuse glioma]. No shinkei geka. Neurological surgery, 2005, Volume: 33, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinases; Drug Administration Schedule; Etoposide; Female; Genes, p53; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Proteasome Endopeptidase Complex; Proteins; Tumor Suppressor Proteins	2005
High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results. Neurosurgery, 1984, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Glioblastoma; Glioma; Humans; Lomustine; Teniposide	1984
[Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma]. Bulletin du cancer, 2001, Volume: 88, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Glioma; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Transplantation, Autologous	2001
High dose chemotherapy in solid tumours in adults. Clinics in haematology, 1986, Volume: 15, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Carmustine; Cell Separation; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Etoposide; Glioma; Humans; Lung Neoplasms; Male; Melanoma; Melphalan; Neoplasms; Testicular Neoplasms; Whole-Body Irradiation	1986

Trials

45 trial(s) available for etoposide and Glial Cell Tumors

Article	Year
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors. Journal of neuro-oncology, 2013, Volume: 113, Issue:3 Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Temozolomide	2013
[Radiotherapy of malignant brain gliomas using teniposide]. Voprosy onkologii, 2008, Volume: 54, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Chemotherapy, Adjuvant; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome	2008
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. British journal of cancer, 2009, Dec-15, Volume: 101, Issue:12 Topics: Administration, Oral; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Failure; Vascular Endothelial Growth Factor A	2009
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. Journal of neuro-oncology, 2010, Volume: 100, Issue:1 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Electroencephalography; Etoposide; Evoked Potentials, Visual; Female; Glioma; Humans; Infant; Infant, Newborn; Longitudinal Studies; Magnetic Resonance Imaging; Male	2010
Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas. Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Infant, Newborn; Lomustine; Male; Procarbazine; Retrospective Studies; Survival Rate; Thioguanine; Vinblastine; Vincristine	2011
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-15, Volume: 20, Issue:16 Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Male; Neoadjuvant Therapy; Survival Rate; Vincristine	2002
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Oct-15, Volume: 20, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Glioma; Hearing Disorders; Humans; Infant; Magnetic Resonance Imaging; Male; Survival Analysis	2002
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. British journal of cancer, 2002, Oct-21, Volume: 87, Issue:9 Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Pons; Postoperative Care; Survival Rate; Treatment Outcome	2002
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Cancer, 2003, Apr-15, Volume: 97, Issue:8 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Temozolomide; Treatment Outcome	2003
Response to a phase II study of concomitant-to-sequential use of etoposide and radiation therapy in newly diagnosed malignant gliomas. American journal of clinical oncology, 2003, Volume: 26, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Supratentorial Neoplasms; Survival Analysis	2003
Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Pediatric blood & cancer, 2004, Volume: 43, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Glioma; Humans; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pilot Projects; Statistics, Nonparametric; Survival Rate; Vincristine	2004
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. British journal of cancer, 2004, Sep-13, Volume: 91, Issue:6 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Glioma; Humans; In Situ Hybridization; Male; Survival Analysis	2004
Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH). Journal of neuro-oncology, 2005, Volume: 72, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Male; Neoplasm Invasiveness; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine	2005
Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatric blood & cancer, 2005, Oct-15, Volume: 45, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Dose Fractionation, Radiation; Etoposide; Glioma; Humans; Radiotherapy Dosage; Vincristine	2005
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine	2005
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors. Journal of neuro-oncology, 2006, Volume: 79, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Loss of Heterozygosity; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome	2006
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. Journal of neuro-oncology, 2006, Volume: 80, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Fluorouracil; Glioma; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Prospective Studies; Treatment Outcome; Vincristine	2006
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors. Journal of neuro-oncology, 2007, Volume: 82, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Tomography, X-Ray Computed	2007
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. Pediatric blood & cancer, 2008, Volume: 50, Issue:2 Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Combined Modality Therapy; Etoposide; Glioma; Humans; Radiotherapy; Survival Rate; Treatment Outcome; Vincristine	2008
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro-oncology, 2007, Volume: 9, Issue:3 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyrazoles; Sulfonamides; Thalidomide	2007
Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cranial Nerve Neoplasms; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Male; Neoplasm Recurrence, Local; Optic Chiasm; Salvage Therapy	1995
Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. Archives of neurology, 1995, Volume: 52, Issue:5 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cranial Nerve Neoplasms; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Male; Neoplasm Recurrence, Local; Optic Chiasm; Salvage Therapy	1995
Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial. Statistics in medicine, 1993, Dec-30, Volume: 12, Issue:24 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bias; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Regression Analysis; Survival Analysis; Treatment Outcome	1993
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. Journal of neuro-oncology, 1996, Volume: 27, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Evaluation Studies as Topic; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms	1996
Contemporary chemotherapy issues for children with brainstem gliomas. Pediatric neurosurgery, 1996, Volume: 24, Issue:2 Topics: Antineoplastic Agents; Brain Neoplasms; Brain Stem; Carboplatin; Carmustine; Dose-Response Relationship, Drug; Etoposide; Glioma; Humans; Neoplasm Recurrence, Local; Thiotepa; Vincristine	1996
Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Glioma; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Survival Rate; Tomography, X-Ray Computed	1996
Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Survival Rate; Thiotepa	1997
Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. Journal of neuro-oncology, 1997, Volume: 32, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Treatment Outcome	1997
Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study. Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thiotepa	1997
Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide. Archives of neurology, 1997, Volume: 54, Issue:5 Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Time Factors	1997
Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. Medical and pediatric oncology, 1998, Volume: 30, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Pons; Radiotherapy, Adjuvant; Treatment Outcome	1998
A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas--an Eastern Cooperative Oncology Group Study (E2392). Journal of neuro-oncology, 1998, Volume: 37, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Middle Aged; Procarbazine; Prognosis; Survival Analysis; Vincristine	1998
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults. Journal of neuro-oncology, 1998, Volume: 39, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine	1998
[A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Survival Rate	1998
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma. International journal of radiation oncology, biology, physics, 1998, Dec-01, Volume: 42, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Survival Analysis	1998
Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center. Journal of surgical oncology, 1999, Volume: 71, Issue:3 Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Carboplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Treatment Failure; Treatment Outcome	1999
Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas. Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Survival Analysis	1999
Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP). British journal of cancer, 1999, Volume: 81, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Follow-Up Studies; Glioma; Humans; Infant; Neoplasm Recurrence, Local; Procarbazine; Spinal Cord Neoplasms; Vincristine	1999
Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma. Journal of neuro-oncology, 1999, Volume: 44, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1999
A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas. Journal of neuro-oncology, 2000, Volume: 49, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Survival Analysis; Treatment Outcome	2000
Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study. Journal of neuro-oncology, 2001, Volume: 51, Issue:1 Topics: Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Angiography; Cisplatin; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome	2001
Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas. Journal of neuro-oncology, 2002, Volume: 56, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Glioma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Treatment Outcome	2002
Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma. Italian journal of neurological sciences, 1992, Volume: 13, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Etoposide; Glioma; Humans; Middle Aged; Survival Analysis	1992
Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results. Italian journal of neurological sciences, 1991, Volume: 12, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Glioblastoma; Glioma; Humans; Middle Aged	1991
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. Journal of neuro-oncology, 1991, Volume: 11, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis	1991

Other Studies

108 other study(ies) available for etoposide and Glial Cell Tumors

Article	Year
Cell-based screen for identification of inhibitors of tubulin polymerization. Journal of natural products, 1996, Volume: 59, Issue:12 Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured	1996
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica. Journal of natural products, 2001, Volume: 64, Issue:10 Topics: Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catalysis; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Electrophoresis, Agar Gel; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Female; Glioma; Humans; Inhibitory Concentration 50; Lung Neoplasms; Methyl Green; Molecular Structure; Plants, Medicinal; Saccharomyces cerevisiae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triterpenes; Tumor Cells, Cultured	2001
N⁴-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: cytotoxicity against human tumor cells, structure-activity relationship studies and investigation on the mechanism of action. Bioorganic & medicinal chemistry, 2012, Jun-01, Volume: 20, Issue:11 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Humans; Inhibitory Concentration 50; Microtubules; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones; Tubulin; Tumor Suppressor Protein p53	2012
Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma. Annals of palliative medicine, 2021, Volume: 10, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Glioma; Humans; Retrospective Studies; Treatment Outcome	2021
Long-stranded non-coding RNA HCG11 regulates glioma cell proliferation, apoptosis and drug resistance via the sponge MicroRNA-144COX-2 axis. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Feb-27, Volume: 67, Issue:6 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Humans; Imatinib Mesylate; MicroRNAs; RNA, Long Noncoding	2022
Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress. International journal of molecular sciences, 2020, Jun-15, Volume: 21, Issue:12 Topics: Brain Neoplasms; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Damage; DNA Polymerase I; DNA Repair; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Humans; Indazoles; Piperidines; Radiation, Ionizing; Survival Analysis; Up-Regulation	2020
Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model. Scientific reports, 2021, 03-22, Volume: 11, Issue:1 Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Stem; Brain Stem Neoplasms; Disease Models, Animal; Drug Delivery Systems; Etoposide; Evans Blue; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Mice; Pons; Proto-Oncogene Proteins c-sis; PTEN Phosphohydrolase; Tumor Suppressor Protein p53; Ultrasonography	2021
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2018, Volume: 194, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cohort Studies; Dacarbazine; Etoposide; Female; Glioma; Humans; Ifosfamide; Leukopenia; Male; Neoplasm Grading; Prospective Studies; Temozolomide; Treatment Outcome; Vincristine	2018
Application of Albumin-embedded Magnetic Nanoheaters for Release of Etoposide in Integrated Chemotherapy and Hyperthermia of U87-MG Glioma Cells. Anticancer research, 2018, Volume: 38, Issue:5 Topics: Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Drug Carriers; Drug Screening Assays, Antitumor; Etoposide; Glioma; Humans; Hyperthermia, Induced; Magnetics; Molecular Structure; Nanoparticles; Serum Albumin, Human; Topoisomerase II Inhibitors	2018
miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of FOXO1. Oncology research, 2019, Jun-21, Volume: 27, Issue:6 Topics: 3' Untranslated Regions; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioma; Humans; MicroRNAs; Mitochondria; RNA Interference	2019
Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma. Pediatric blood & cancer, 2014, Volume: 61, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Case-Control Studies; Celecoxib; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Neoplasm Grading; Prognosis; Pyrazoles; Quality of Life; Remission Induction; Sulfonamides; Survival Rate; Thalidomide; Topotecan	2014
Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells. The international journal of biochemistry & cell biology, 2014, Volume: 53 Topics: Androstadienes; Cell Line, Tumor; Cisplatin; DNA Breaks, Double-Stranded; DNA Damage; DNA End-Joining Repair; DNA-Activated Protein Kinase; Drug Synergism; Etoposide; Glioma; Humans; Wortmannin	2014
Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines. Investigational new drugs, 2014, Volume: 32, Issue:5 Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Etoposide; Female; Glioma; Humans; Liver Neoplasms; Melphalan; Mice, Inbred BALB C; Neuroblastoma; Podophyllotoxin; Radiation, Ionizing; Spermine	2014
Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles. Cell biochemistry and biophysics, 2015, Volume: 72, Issue:1 Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioma; Inhibitory Concentration 50; Lipids; Multidrug Resistance-Associated Proteins; Nanoparticles; Rats; RNA, Small Interfering; Transfection	2015
The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines. Anticancer research, 2015, Volume: 35, Issue:3 Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Genes, p53; Glioma; Humans; Inhibitor of Apoptosis Proteins; Mutation; PTEN Phosphohydrolase; Silybin; Silymarin; Survivin; Temozolomide	2015
D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH. Cell death & disease, 2015, Mar-26, Volume: 6 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Ketoglutarate Dehydrogenase Complex; Mitochondria; Mutation; NAD	2015
YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors. Molecular cancer research : MCR, 2015, Volume: 13, Issue:10 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Cell Line, Tumor; Circular Dichroism; Colorectal Neoplasms; DNA Breaks, Double-Stranded; DNA Repair; Drug Synergism; Etoposide; Glioma; High-Throughput Screening Assays; Humans; Intercalating Agents; Mice; Mice, Nude; Molecular Structure; Neoplasms; Osteosarcoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiation-Sensitizing Agents; Small Molecule Libraries; Sulfonamides; Xenograft Model Antitumor Assays	2015
Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content. The Journal of biological chemistry, 2015, Oct-02, Volume: 290, Issue:40 Topics: Animals; Antineoplastic Agents; Biomarkers; Brain Neoplasms; Cell Line, Tumor; Cetuximab; Culture Media, Conditioned; DNA; ErbB Receptors; Etoposide; Exosomes; Extracellular Vesicles; Glioma; Humans; Mice; Mice, SCID; Morpholines; Neoplasm Transplantation; Neoplasms; Phosphoproteins; Phosphorylation; Proteomics; Quinazolinones; Transfection	2015
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma. Chemotherapy, 2014, Volume: 60, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Retrospective Studies	2014
Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents. Journal of Korean medical science, 2017, Volume: 32, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Male; Neoplasm Grading; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome	2017
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs. British journal of cancer, 2008, Jul-22, Volume: 99, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Carboplatin; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Hepatocytes; Humans; Lomustine; Male; Membrane Glycoproteins; Middle Aged; Procarbazine; Recombinant Fusion Proteins; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine	2008
Differential regulation of the antiapoptotic action of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma extra long (Bcl-xL) by c-Jun N-terminal protein kinase (JNK) 1-involved pathway in neuroglioma cells. Biological & pharmaceutical bulletin, 2008, Volume: 31, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; bcl-X Protein; Blotting, Western; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Enzyme Activation; Etoposide; Glioma; Humans; Mitogen-Activated Protein Kinase 8; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transfection	2008
Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide. Neurochemical research, 2009, Volume: 34, Issue:5 Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Silencing; Glioma; Humans; Hypoxia-Inducible Factor 1; Multidrug Resistance-Associated Proteins; RNA, Small Interfering	2009
Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma. Pediatric blood & cancer, 2009, Volume: 53, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; DNA Methylation; Etoposide; Female; Glioma; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Nitrosourea Compounds; Retrospective Studies; Temozolomide; Treatment Outcome	2009
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide. Cancer science, 2009, Volume: 100, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzimidazoles; Caspases; Catalysis; Cell Line, Tumor; Cell Survival; Coenzyme A Ligases; Cytochrome c Group; Dose-Response Relationship, Drug; Etoposide; Fluorescent Antibody Technique; Fluorescent Dyes; Glioma; Humans; Indoles; Injections, Subcutaneous; Isoenzymes; Mice; Mice, Nude; Neoplasm Transplantation; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Triazenes; Tumor Burden; Xenograft Model Antitumor Assays	2009
Population analysis of myelosuppression profiles using routine clinical data after the ICE (ifosfamide/carboplatin/etoposide) regimen for malignant gliomas. Journal of pharmaceutical sciences, 2009, Volume: 98, Issue:11 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Computer Simulation; Etoposide; Female; Glioma; Humans; Ifosfamide; Immunosuppressive Agents; Kinetics; Leukocyte Count; Male; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Platelet Count; Reticulocyte Count; Retrospective Studies	2009
Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas. Acta paediatrica (Oslo, Norway : 1992), 2011, Volume: 100, Issue:1 Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Celecoxib; Child; Child, Preschool; Disease Progression; Etoposide; Glioma; Humans; Pilot Projects; Pyrazoles; Quality of Life; Radiation-Sensitizing Agents; Sulfonamides; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome	2011
ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy. Pediatric blood & cancer, 2011, Jul-01, Volume: 56, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Melphalan; Radiotherapy Dosage; Remission Induction; Second-Look Surgery; Spinal Neoplasms; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine	2011
Pro-apoptotic role of integrin β3 in glioma cells. Journal of neurochemistry, 2011, Volume: 117, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carmustine; Cell Line, Tumor; Drug Interactions; Enzyme Inhibitors; Etoposide; Flow Cytometry; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glioma; Humans; Integrin beta3; Nitric Oxide; Rats; RNA, Messenger; Signal Transduction; Statistics as Topic; Tetrazolium Salts; Thiazoles; Vitronectin	2011
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma. Oncology, 2011, Volume: 80, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Temozolomide; Treatment Failure	2011
Avastin: more questions than answers. . . Journal of neurosurgery, 2012, Volume: 116, Issue:2 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Dacarbazine; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Supratentorial Neoplasms; Temozolomide	2012
PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway. Cancer biology & therapy, 2012, Volume: 13, Issue:9 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cisplatin; Etoposide; Gene Expression; Gene Knockdown Techniques; Glioma; Humans; Mitochondria; Neoplasm Proteins; RNA Interference; Vincristine	2012
Sensitization of glioma cells by X-linked inhibitor of apoptosis protein knockdown. Oncology, 2012, Volume: 83, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Caspases; Cellular Senescence; Central Nervous System Neoplasms; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; Glioma; Humans; RNA, Small Interfering; Tumor Suppressor Protein p53; Vincristine; X-Linked Inhibitor of Apoptosis Protein	2012
Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency. Journal of biomedical materials research. Part A, 2013, Volume: 101, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Carriers; Etoposide; Glioma; Humans; Lactic Acid; Mice; Monocytes; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties	2013
An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents. Cancer research, 2002, Oct-15, Volume: 62, Issue:20 Topics: Antigens, Nuclear; Antineoplastic Agents; Bleomycin; Chlorambucil; Cisplatin; DNA Helicases; DNA-Activated Protein Kinase; DNA-Binding Proteins; Etoposide; Glioma; Humans; Kinetics; Ku Autoantigen; Nuclear Proteins; Oligonucleotides, Antisense; Protein Serine-Threonine Kinases; RNA, Messenger; Substrate Specificity; Transfection; Tumor Cells, Cultured	2002
Human malignant glioma cell lines are sensitive to low radiation doses. International journal of cancer, 2003, May-20, Volume: 105, Issue:1 Topics: Animals; Brain Neoplasms; Cell Survival; Dose-Response Relationship, Radiation; Etoposide; Female; Glioma; Humans; Mice; Neoplasm Transplantation; Radiation Tolerance; Time Factors; Tumor Cells, Cultured	2003
In vitro growth suppression of human glioma cells by a 16-mer oligopeptide: a potential new treatment modality for malignant glioma. Journal of neuro-oncology, 2003, Volume: 63, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Division; Cisplatin; Drug Synergism; Etoposide; Fibroblast Growth Factor 2; Glioma; Humans; Nimustine; Oligopeptides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Antisense; Signal Transduction; Tumor Cells, Cultured	2003
Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells. Cancer research, 2003, Jul-15, Volume: 63, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromones; Cisplatin; Drug Synergism; Enzyme Inhibitors; Etoposide; Glioma; Humans; Microtubules; Morpholines; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Tumor Cells, Cultured; Vincristine	2003
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. Journal of neuro-oncology, 2004, Volume: 66, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Glioma; Humans; Indomethacin; Male; Middle Aged; Osmolar Concentration; Vincristine	2004
[Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:1 Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Polymers	2004
Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death. Journal of neurochemistry, 2004, Volume: 89, Issue:6 Topics: Antineoplastic Agents; beta-D-Galactoside alpha 2-6-Sialyltransferase; Caspase 3; Caspases; Cell Death; Cell Line, Tumor; Cell Membrane; Cell Survival; Chromones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Glioma; Glycoconjugates; Glycosylation; Humans; Morpholines; N-Acetylglucosaminyltransferases; Oligosaccharides; Sialyltransferases; Sphingosine; Staurosporine; Transfection	2004
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines. Cancer biology & therapy, 2004, Volume: 3, Issue:9 Topics: Adenosine Triphosphate; Antimetabolites; Antineoplastic Agents, Phytogenic; Benzimidazoles; Brain Neoplasms; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Deoxyglucose; DNA Damage; Drug Interactions; Enzyme Inhibitors; Etoposide; Glioma; Humans; Radiation-Sensitizing Agents; Topoisomerase Inhibitors; Tumor Cells, Cultured	2004
Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2. The journal of medical investigation : JMI, 2005, Volume: 52, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; Base Sequence; Biological Transport, Active; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA, Antisense; DNA, Complementary; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gene Expression; Glioma; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; RNA, Messenger; RNA, Neoplasm; Topoisomerase II Inhibitors	2005
Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity. Neurological research, 2005, Volume: 27, Issue:1 Topics: Apoptosis; Benzimidazoles; Blotting, Southern; Blotting, Western; Caspase 3; Caspases; Cell Count; Cell Line, Tumor; Cell Proliferation; Colorimetry; Cyclin D1; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Endopeptidases; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Humans; Insulin-Like Growth Factor I; Nerve Tissue Proteins; Nucleic Acid Synthesis Inhibitors; Oligodeoxyribonucleotides, Antisense; Receptor, IGF Type 1; Tetrazolium Salts; Thiazoles; Time Factors; Transfection	2005
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas. Pediatric blood & cancer, 2006, Volume: 47, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Etoposide; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome	2006
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. Journal of neuro-oncology, 2006, Volume: 77, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Delivery Systems; Etoposide; Female; Glioma; Humans; Male; Methotrexate; Osmosis; Retrospective Studies; Treatment Outcome	2006
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine	2007
Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. Journal of controlled release : official journal of the Controlled Release Society, 2006, May-15, Volume: 112, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Drug Carriers; Etoposide; Glioma; Lipids; Nanostructures; Rats	2006
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology, 2006, Apr-25, Volume: 66, Issue:8 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Camptothecin; Carboplatin; Drug Therapy, Combination; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Vascular Endothelial Growth Factor A	2006
Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells. Glycobiology, 2006, Volume: 16, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Caspases; Cell Line, Tumor; DNA, Antisense; Down-Regulation; Etoposide; Galactosyltransferases; Glioma; Humans; Plant Lectins; Polysaccharides; Promoter Regions, Genetic; RNA, Messenger; Sp1 Transcription Factor	2006
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell death and differentiation, 2007, Volume: 14, Issue:3 Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Death; Cell Line, Tumor; Dacarbazine; DNA Damage; Etoposide; Glioma; Humans; Membrane Proteins; Oxidation-Reduction; Phosphorylation; Temozolomide	2007
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:17 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Male; Neoplasm, Residual; Procarbazine; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine	2006
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas. British journal of cancer, 2006, Oct-23, Volume: 95, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Infant; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Pons; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine	2006
[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nausea; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Remission Induction; Temozolomide; Young Adult	2006
The combined effects of multiple chemotherapeutic agents for malignant glioma cells. Journal of neuro-oncology, 2007, Volume: 84, Issue:1 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Etoposide; Glioma; Humans; Models, Statistical; Nimustine; Vincristine	2007
[Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases]. No shinkei geka. Neurological surgery, 2007, Volume: 35, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Infant; Male; Optic Chiasm; Optic Nerve Glioma; Vincristine	2007
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences of the United States of America, 2008, Jun-17, Volume: 105, Issue:24 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cyclophosphamide; Cytoprotection; Etoposide; Fasting; Female; Glioma; Glucose; Humans; Mice; Mice, Inbred Strains; Neuroblastoma; Oxidative Stress; Proto-Oncogene Mas; Rats; Reactive Oxygen Species; Saccharomyces cerevisiae	2008
End-stage dying glioma cells are engulfed by mouse microglia with a strain-dependent efficacy. Journal of neuroimmunology, 2008, Jun-15, Volume: 197, Issue:1 Topics: Animals; Apoptosis; Cell Line, Tumor; Cells, Cultured; Disease Models, Animal; Etoposide; Glioma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microglia; Microscopy, Video; Phagocytosis; Species Specificity; Time Factors	2008
Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors. Journal of neuro-oncology, 1984, Volume: 2, Issue:2 Topics: Brain Neoplasms; Etoposide; Glioma; Half-Life; Humans; Kinetics; Necrosis; Neoplasms; Podophyllotoxin	1984
Etoposide (VP-16-213) in malignant brain tumors: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Evaluation; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Time Factors; Tomography, X-Ray Computed	1984
Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. International journal of cancer, 1994, Sep-15, Volume: 58, Issue:6 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Southern; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Gene Expression; Glioma; Humans; Microscopy, Fluorescence; Phenotype; RNA, Messenger; Tumor Cells, Cultured; Vincristine	1994
[Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin]. No shinkei geka. Neurological surgery, 1994, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Arteries; Cisplatin; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Infusions, Intravenous	1994
Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report. Surgical neurology, 1994, Volume: 41, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Treatment Outcome	1994
Analysis and distribution of etoposide in rat brain tumor model: intracarotid versus intracarotid with angiotensin II-induced hypertension. Cancer investigation, 1993, Volume: 11, Issue:3 Topics: Angiotensin II; Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Neoplasms; Carotid Arteries; Etoposide; Glioma; Injections, Intra-Arterial; Pseudotumor Cerebri; Rats; Rats, Inbred F344	1993
Recurrent brainstem gliomas treated with oral VP-16. Journal of neuro-oncology, 1993, Volume: 15, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1993
Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor. Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Arteries; Cisplatin; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Meningeal Neoplasms	1996
Visual pathway glioma: an erratic tumour with therapeutic dilemmas. Archives of disease in childhood, 1997, Volume: 76, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Cranial Nerve Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Optic Chiasm; Optic Nerve Diseases; Vincristine; Visual Cortex	1997
Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha. Neurologia medico-chirurgica, 1997, Volume: 37, Issue:9 Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Division; Cell Line, Transformed; Cell Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Enzymologic; Glioma; Humans; Isoenzymes; Oligonucleotides, Antisense; RNA, Messenger; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1997
Etoposide sensitivity of radioresistant human glioma cell lines. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:2 Topics: Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; Etoposide; Glioma; Humans; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1998
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts. Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Chemical and Drug Induced Liver Injury; Cisplatin; Drug Screening Assays, Antitumor; Ellipticines; Etoposide; Feasibility Studies; Female; Glioma; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Nude; Neoplasm Transplantation; Survival Rate; Transplantation, Heterologous	1998
In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance. Journal of neuro-oncology, 1998, Volume: 36, Issue:1 Topics: Animals; Antigens, Neoplasm; Antigens, Nuclear; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Nucleus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Etoposide; Glioma; Isoenzymes; Mice; Mice, Nude; Neoplasm Transplantation; Nuclear Proteins; Rats; RNA, Messenger; Tumor Cells, Cultured	1998
Carboplatin and etoposide for recurrent malignant glioma: one department's experience. American journal of clinical oncology, 1998, Volume: 21, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged	1998
The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochemical and biophysical research communications, 1998, Jun-09, Volume: 247, Issue:1 Topics: Androstadienes; DNA Damage; DNA-Activated Protein Kinase; DNA-Binding Proteins; Etoposide; Gamma Rays; Glioma; HeLa Cells; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Nuclear Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Wortmannin	1998
Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. Journal of neuro-oncology, 1998, Volume: 39, Issue:3 Topics: Antigens, Neoplasm; Antineoplastic Agents; B7-1 Antigen; Cytokines; Down-Regulation; Etoposide; Flow Cytometry; Glioma; Histocompatibility Antigens Class I; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-10; Transforming Growth Factor beta; Tumor Cells, Cultured; Vincristine	1998
Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model. Acta medica Okayama, 1999, Volume: 53, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Carboplatin; Carotid Arteries; Etoposide; Glioma; Injections, Intra-Arterial; Male; Neoplasm Transplantation; Permeability; Rats; Rats, Wistar; Tumor Cells, Cultured	1999
Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy. Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Etoposide; Glioma; Half-Life; Humans; Middle Aged; Osmosis	1999
Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation. Journal of neuro-oncology, 1999, Volume: 41, Issue:3 Topics: Brain Neoplasms; Camptothecin; Cell Survival; Colonic Neoplasms; DNA Damage; Drug Synergism; Etoposide; Glioblastoma; Glioma; Humans; Mitotic Index; Phosphotyrosine; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1999
Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs. Japanese journal of clinical oncology, 1999, Volume: 29, Issue:11 Topics: Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cisplatin; Doxorubicin; Etoposide; Genes, MDR; Glioma; Humans; Membrane Glycoproteins; Nimustine; RNA, Messenger; Tetraspanin 29; Tumor Cells, Cultured	1999
[Chemotherapy of malignant inoperable gliomas. The association of fotemustine-cisplatine-etoposide as neoadjuvants]. Revue neurologique, 2000, Volume: 156, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Organophosphorus Compounds; Treatment Outcome	2000
Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells. Brain research bulletin, 2000, Mar-15, Volume: 51, Issue:5 Topics: Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cell Division; Electric Stimulation; Etoposide; Glioma; Humans; Nimustine; Rats; Tumor Cells, Cultured; Vincristine	2000
Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line. Journal of neuro-oncology, 1999, Volume: 45, Issue:1 Topics: Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Cell Division; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Etoposide; Gene Deletion; Glioma; Humans; Multidrug Resistance-Associated Proteins; Mutation; Phosphorylation; RNA, Messenger	1999
Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene, 2000, Jul-20, Volume: 19, Issue:31 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Brain Neoplasms; Caspases; Ceramides; Cisplatin; Culture Media, Serum-Free; Cytochrome c Group; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Glioblastoma; Glioma; Humans; Mitochondria; Neoplasm Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Recombinant Fusion Proteins; Sphingomyelin Phosphodiesterase; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2000
Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells. Journal of neurosurgery, 2000, Volume: 93, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Caspase 1; Caspase 3; Caspases; Dose-Response Relationship, Drug; Etoposide; Genes, bcl-2; Genes, p53; Glioma; Humans; Tumor Cells, Cultured	2000
[Correlation between DNA topoisomerase II alpha expression and sensitivity to etoposide in human glioma cell lines]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:9 Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Cell Division; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Flow Cytometry; Glioma; Humans; Immunohistochemistry; Isoenzymes; Tumor Cells, Cultured	2000
Retrovirus vector containing wild type p53 gene and its effect on human glioma cells. Neoplasma, 2000, Volume: 47, Issue:4 Topics: 3T3 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Doxorubicin; Etoposide; Genes, p53; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Retroviridae; Transfection; Tumor Suppressor Protein p53	2000
Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer research, 2000, Oct-15, Volume: 60, Issue:20 Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Cricetinae; Cricetulus; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Fibroblasts; Glioma; Humans; Isoenzymes; Mice; Mice, Inbred NOD; Mice, SCID; Spheroids, Cellular; Subcellular Fractions; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2000
The ability in adhesion and invasion of drug-resistant human glioma cells. Journal of experimental & clinical cancer research : CR, 2000, Volume: 19, Issue:3 Topics: Animals; Brain Neoplasms; Cell Adhesion; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Extracellular Matrix Proteins; Flow Cytometry; Glioma; Humans; Matrix Metalloproteinases; Mice; Neoplasm Proteins; Neural Cell Adhesion Molecules; Nimustine; Tumor Cells, Cultured; Vincristine	2000
FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells. Biochemical and biophysical research communications, 2001, Feb-23, Volume: 281, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 6; Caspases; Cell Death; Cell Survival; Cysteine Proteinase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Etoposide; Fingolimod Hydrochloride; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; Immunosuppressive Agents; Oligopeptides; Phosphatidylinositol 3-Kinases; Phosphorylation; Propylene Glycols; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sphingosine; Time Factors; Tumor Cells, Cultured; Tyrosine; Vanadates	2001
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:2 Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Interactions; Epilepsy; Etoposide; Female; Glioma; Hematologic Tests; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Thrombocytopenia; Valproic Acid	2001
p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene, 2001, Mar-15, Volume: 20, Issue:11 Topics: Apoptosis; Ceramides; Etoposide; Gene Expression Regulation; Glioma; Humans; Pyrogallol; Reactive Oxygen Species; Sphingomyelin Phosphodiesterase; Superoxides; Tumor Suppressor Protein p53	2001
Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children. AJNR. American journal of neuroradiology, 2001, Volume: 22, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Infant; Infant, Newborn; Infusions, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Male; Treatment Outcome; Visual Pathways	2001
Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:4 Topics: Adenoviridae; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-X Protein; Caspase 9; Caspases; Etoposide; Genes, p53; Genetic Vectors; Glioma; Humans; Mutation; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins c-bcl-2; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2001
Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: results of a pilot study. Japanese journal of clinical oncology, 2001, Volume: 31, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Pilot Projects; Prognosis; Supratentorial Neoplasms	2001
Diazepam enhances etoposide-induced cytotoxicity in U-87 MG human glioma cell line. Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:3 Topics: Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Diazepam; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Glioma; Humans; Tumor Cells, Cultured	2001
Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants. British journal of cancer, 2001, Sep-28, Volume: 85, Issue:7 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Glioma; Rats; Rats, Wistar; Tumor Cells, Cultured	2001
Response of short-term cultures derived from human malignant glioma to aziridinylbenzoquinone, etoposide and doxorubicin: an in vitro phase II trial. Anti-cancer drugs, 2001, Volume: 12, Issue:9 Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Glioma; Humans; Tumor Cells, Cultured	2001
Penetration of etoposide into human malignant brain tumors after intravenous and oral administration. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Brain Neoplasms; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Injections, Intravenous; Lymphoma; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Time Factors	1992
Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. Journal of neurosurgery, 1991, Volume: 74, Issue:3 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line; Doxorubicin; Drug Resistance; Etoposide; Gene Expression; Glioma; Humans; Immunohistochemistry; Membrane Glycoproteins; Vincristine	1991
[A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local	1992
Primary glial tumor patients treated by combining cis-platin and etoposide. Journal of neuro-oncology, 1991, Volume: 11, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Drug Synergism; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate	1991
Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation. International journal of cancer, 1991, Jul-30, Volume: 48, Issue:6 Topics: Animals; Buthionine Sulfoximine; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance; Etoposide; Glioma; Glutathione; Kinetics; Methionine Sulfoximine; Nimustine; Pyrrolidonecarboxylic Acid; Rats; Thiazoles; Thiazolidines; Vinblastine	1991
[Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension]. No to shinkei = Brain and nerve, 1991, Volume: 43, Issue:7 Topics: Angiotensin II; Animals; Blood Pressure; Brain; Brain Neoplasms; Etoposide; Glioma; Male; Rats; Rats, Inbred F344; Regional Blood Flow	1991
[Therapeutic efficacy of etoposide injected via carotid artery with angiotensin II-induced hypertension in experimental rat gliomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Brain Neoplasms; Carotid Artery, Internal; Combined Modality Therapy; Etoposide; Glioma; Injections, Intra-Arterial; Male; Rats; Rats, Inbred F344	1991
Amplification and expression of a multidrug resistance gene in human glioma cell lines. Journal of neurosurgery, 1990, Volume: 72, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Doxorubicin; Drug Resistance; Etoposide; Gene Amplification; Gene Expression; Glioma; Humans; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Vincristine	1990
[Etoposide delivery to malignant brain tumors by induced hypertension with angiotensin II]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Brain; Brain Neoplasms; Carotid Artery, Internal; Etoposide; Glioma; Infusions, Intra-Arterial; Male; Rats; Rats, Inbred F344	1990
[Effect of high-dose cyclophosphamide plus high-dose etoposide in malignant brain tumors of children followed by autologous bone marrow rescue]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioma; Humans; Male; Remission Induction; Transplantation, Autologous	1989
Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer, 1988, Jul-01, Volume: 62, Issue:1 Topics: Acute Disease; Bone Marrow Transplantation; Brain Neoplasms; Dexamethasone; Etoposide; Glioma; Humans; Nervous System Diseases	1988
Intracarotid VP-16 in malignant brain tumors. Journal of neuro-oncology, 1987, Volume: 4, Issue:4 Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Carotid Artery, Internal; Child; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged	1987